X-Energy (XE) Q3 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2026 earnings summary
12 Nov, 2026Executive summary
Q3 advanced licensing, customer development, fuel manufacturing and supply-chain readiness; management said 2026 milestones were met on time or early.
Revenue and grant income rose 118% YoY to $66.3M; liquidity was $1.81B with no debt, while commercialization remains dependent on DOE funding and customer commitments.
Financial highlights
Q3 revenue and grant income totaled $66.3M, up 118% YoY, including $51.5M services revenue and $14.8M grant income; 9M totaled $164.4M, up 126%.
Q3 operating expenses rose 139% YoY to $169.9M; operating loss was $103.6M and net loss was $83.7M.
9M operating expenses were $444.1M and operating loss was $279.7M; net loss was $355.2M versus $318.1M in 9M 2025.
Adjusted Q3 net loss was $56.8M and adjusted EBITDA was $(75.7)M; 9M adjusted net loss was $170.0M and adjusted EBITDA was $(207.7)M.
Q3 SG&A included $22M of non-cash equity compensation; interest income was $19.7M.
Outlook and guidance
Dow is expected to consider a preliminary investment decision in 2027; full-scale construction follows its final investment decision.
The first Dow project is expected online in the early 2030s; NRC operating-license review is expected to take ~18 months, with filing anticipated ~2 years before commissioning.
TX-1's planned capacity supports fuel for up to 11 Xe-100 reactors; TX-2 is planned at Oak Ridge with capacity to support up to 44 reactors annually.
The 144-reactor U.S. and U.K. pipeline represents ~11.5 GWe if customers exercise contingent rights in full; the U.K. GDA review is expected to take ~3 years.
Near-term priorities include Dow engineering and procurement, AEP feasibility and site characterization, Xe-100 design completion, XTAC testing, and TX-1 equipment installation.
Latest events from X-Energy
- Q2 2026 revenues up 154% year-over-year, fueled by ARDP activity and IPO-driven liquidity.XE
Q2 2026 - Q1 revenues up 109% YoY, $1.1B IPO completed, liquidity at $2B, and major milestones achieved.XE
Q1 2026 - Licenses advanced SMR technology and fuel, targeting $2.3T market with strong customer backing.XE
Investor presentation - IPO targets $693.8M to scale advanced nuclear reactors and fuel, with major growth and risk.XE
Registration filing - IPO targets $693.8M to fund advanced nuclear growth, with strong market potential and significant execution risks.XE
Registration filing - IPO aims to fund advanced nuclear reactor and fuel commercialization amid high growth and risk.XE
Registration filing - IPO funds will drive SMR and fuel commercialization amid high growth and execution risks.XE
Registration filing - IPO targets SMR and fuel commercialization in a vast market, but faces high execution risk.XE
Registration filing